NFE2L2 and cancer: Experimental evidence suggests that Nrf2 inhibitors are frequently used in combination with chemotherapeutic drugs to sensitize a broad spectrum of cancer cells to CDDP or other chemotherapeutic drugs by inducing ferroptosis [10,37,38,39].